Back to Search
Start Over
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
- Source :
- The Lancet Regional Health - Americas; December 2021, Vol. 4 Issue: 1
- Publication Year :
- 2021
-
Abstract
- As a first step towards a vaccine protecting COVID-19 convalescents from reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial.
Details
- Language :
- English
- ISSN :
- 2667193X
- Volume :
- 4
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- The Lancet Regional Health - Americas
- Publication Type :
- Periodical
- Accession number :
- ejs57691114
- Full Text :
- https://doi.org/10.1016/j.lana.2021.100079